AMG 691 Clinical Trials (2026): 1 Studies for Asthma
Hipa.ai Research · Source: ClinicalTrials.gov / AACT
Synced daily from ClinicalTrials.gov via AACT. Last sync: .
1 AMG 691 clinical trials are catalogued on Hipa.ai from the AACT mirror of ClinicalTrials.gov, spanning 1 indication (including Asthma) and 21 total planned enrollment. Most recent activity: NCT06637371 (Apr 2027).
AMG 691 clinical trials at a glance: phase × recruitment status
| Phase | active not recruiting | Total |
|---|---|---|
| P1 | 1 | 1 |
All AMG 691 trials (1)
Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.
| NCT ID | Acronym | Title | Phase | Status | Enrollment | Sponsor | Started |
|---|---|---|---|---|---|---|---|
| NCT06637371 | A Phase 1, Randomized, Double-blind, Placebo-controlled Study Evaluating AMG 691 in Healthy Participants and Participants With Mild-to-Moderate Asthma | P1 | active not recruiting | 21 | Amgen | Oct 2024 |
AMG 691 clinical trials: frequently asked questions
- How many AMG 691 clinical trials are there?
- 1 AMG 691 clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov.
- Are AMG 691 clinical trials recruiting in 2026?
- No active AMG 691 trials are recruiting on ClinicalTrials.gov as of the current AACT refresh. Trials may resume; this page is updated daily.
- What conditions is AMG 691 being studied for?
- AMG 691 is being studied for Asthma. The trials are grouped by indication on this page.
- What phase is AMG 691 in?
- AMG 691 clinical trials span 1 Phase 1. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.
- Who sponsors AMG 691 clinical trials?
- The lead sponsor across the most AMG 691 trials is Amgen. Each trial row links to the full study detail page including sponsor information.
Sources and methodology
Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming AMG 691as an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.
Last refreshed .
Related pages on Hipa.ai: